Related Experiment Video
Updated: May 29, 2025

28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
12.3K
Constitutional Mismatch Repair Deficiency: Scoping Review of a Cancer-Predisposition Syndrome With Distinctive
Kristie Mar1, Kimia Ameri1, Joseph M Lam2,3
1Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Pediatric Dermatology
|February 6, 2025
Summary
Constitutional mismatch repair deficiency (CMMRD) is a rare genetic syndrome causing early-onset cancers. This review details CMMRD
Area of Science:
- Genetics and Oncology
- Hereditary Cancer Syndromes
Background:
- Constitutional mismatch repair deficiency (CMMRD) is a rare, severe hereditary cancer predisposition syndrome.
- Caused by biallelic pathogenic variants in mismatch repair genes (MLH1, MSH2, MSH6, PMS2).
- Presents in childhood with hematological, brain, and GI cancers, plus neurofibromatosis type 1-like skin features.
Purpose of the Study:
- To explore the clinical characteristics of Constitutional mismatch repair deficiency (CMMRD).
- To provide a comprehensive overview of CMMRD manifestations and genetic associations.
Main Methods:
- Conducted a scoping review of medical literature.
- Performed a systematic search across medical databases.
- Included 127 relevant articles in the analysis.
Main Results:
- PMS2 is the most frequently affected gene, followed by MSH6, MLH1, and MSH2.
- Early childhood onset for blood and brain cancers across all variants; age of onset decreases with PMS2 to MSH2.
- Gastrointestinal tumors present in late adolescence for PMS2/MSH6 variants; rare in MLH1/MSH2.
- CMMRD patients exhibit larger, fewer café-au-lait macules than NF1 patients; PMS2/MSH6 variants show diverse skin findings (vascular tumors, nevi, pilomatricomas).
Conclusions:
- Advances in diagnostics, genetic testing, and surveillance improve survival and management for CMMRD.
- Understanding CMMRD's diverse clinical spectrum is crucial for early detection and effective patient care.
Related Concept Videos
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K
Nucleotide Excision Repair
3.4K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.4K
Cancers Originate from Somatic Mutations in a Single Cell
11.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.5K
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

